Last updated: 2026-09-16 10:31:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Embecta Corp. (EMBC) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $5.09, with a market capitalisation of $296.90M and a P/E ratio of 3.30. Over the past 52 weeks, its price has ranged from $2.77 to $15.55. This page covers its latest market performance, valuation, price trends and company information.
$296.90M | |
$5.21 | |
$36.64 | |
$2.77 | |
$5.24 | |
637.28K | |
1.79M | |
3.30 | |
$15.55 | |
$2.77 | |
9.43% | |
-- |
Embecta Corp. (EMBC) is trading at $5.19 in pre-market trading as of 2026-09-15 23:31:00, down 1.03% ($0.05) from the previous close of $5.24
Pre-market trading shows how investors are pricing EMBC before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Embecta Corp. (EMBC) moved from $5.80 to $5.09, representing a decline of 12.33% ($0.71).
The stock traded between $4.87 and $5.91 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.14 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 18.1%
EMBC is currently trading at $5.09, placing it 18.1% of the way from its 52-week low of $2.77 to its 52-week high of $15.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 1850 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Embecta Corp. (EMBC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.